Advertisement

American Journal of Clinical Dermatology

, Volume 19, Issue 5, pp 679–694 | Cite as

Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus

  • Siriorn Udompanich
  • Kumutnart Chanprapaph
  • Poonkiat SuchonwanitEmail author
Review Article

Abstract

Cutaneous and systemic lupus erythematosus (SLE) commonly involves the hair and scalp. Alopecia can result from direct activity of disease on the scalp or from the state of physical stress in the form of telogen effluvium. Discoid lupus erythematosus and lupus panniculitis/profundus are known to cause scarring alopecia, while accumulation of recent studies has shown that non-scarring alopecia in SLE may have different subtypes, comprising lupus erythematosus-specific and lupus erythematosus-nonspecific changes on histology. This review aims to summarize the clinical pattern, trichoscopic, histopathological, and direct immunofluorescence features of different types of alopecia in cutaneous and systemic lupus erythematosus, as well as exploring their relationship with SLE disease activity.

Notes

Compliance with Ethical Standards

Funding

No funding was received to assist in the preparation of this review.

Conflicts of interest

Siriorn Udompanich, Kumutnart Chanprapaph, and Poonkiat Suchonwanit have no conflicts of interest to declare.

References

  1. 1.
    Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993;72(2):113–24.CrossRefGoogle Scholar
  2. 2.
    Gong Y, Ye Y, Zhao Y, Caulloo S, Chen X, Zhang B, et al. Severe diffuse non-scarring hair loss in systemic lupus erythematosus: clinical and histopathological analysis of four cases. J Eur Acad Dermatol Venereol. 2013;27(5):651–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Moghadam-Kia S, Franks AG Jr. Autoimmune disease and hair loss. Dermatol Clin. 2013;31(1):75–91.CrossRefPubMedGoogle Scholar
  4. 4.
    Yun SJ, Lee JW, Yoon HJ, Lee SS, Kim SY, Lee JB, et al. Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia. J Dermatol. 2007;34(7):451–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Ferraz LB, Almeida FA, Vasconcellos MR, Faccina AS, Ciconelli RM, Ferraz MB. The impact of lupus erythematosus cutaneous on the quality of life: the Brazilian–Portuguese version of DLQI. Qual Life Res. 2006;15(3):565–70.CrossRefPubMedGoogle Scholar
  6. 6.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRefPubMedGoogle Scholar
  8. 8.
    Ines L, Silva C, Galindo M, Lopez-Longo FJ, Terroso G, Romao VC, et al. Classification of systemic lupus erythematosus: systemic lupus international collaborating clinics versus american college of rheumatology criteria. A comparative study of 2,055 patients from a real-life, International Systemic Lupus Erythematosus Cohort. Arthritis Care Res (Hoboken). 2015;67(8):1180–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Costner MI, Sontheimer RD. Lupus Erythematosus. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill; 2008. p. 1909–26.Google Scholar
  11. 11.
    Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91.PubMedGoogle Scholar
  12. 12.
    Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005;44(7):902–6.CrossRefGoogle Scholar
  13. 13.
    Wysenbeek AJ, Leibovici L, Amit M, Weinberger A. Alopecia in systemic lupus erythematosus. Relation to disease manifestations. J Rheumatol. 1991;18(8):1185–6.PubMedGoogle Scholar
  14. 14.
    Rakowska A, Slowinska M, Kowalska-Oledzka E, Warszawik O, Czuwara J, Olszewska M, et al. Trichoscopy of cicatricial alopecia. J Drugs Dermatol. 2012;11(6):753–8.PubMedGoogle Scholar
  15. 15.
    Rudnicka L, Olszewska M, Rakowska A, Slowinska M. Trichoscopy update 2011. J Dermatol Case Rep. 2011;5(4):82–8.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Duque-Estrada B, Tamler C, Sodre CT, Barcaui CB, Pereira FB. Dermoscopy patterns of cicatricial alopecia resulting from discoid lupus erythematosus and lichen planopilaris. An Bras Dermatol. 2010;85(2):179–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Sperling LC, Solomon AR, Whiting DA. A new look at scarring alopecia. Arch Dermatol. 2000;136(2):235–42.CrossRefPubMedGoogle Scholar
  18. 18.
    Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol. 1997;36(1):59–66.CrossRefPubMedGoogle Scholar
  19. 19.
    Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias. J Am Acad Dermatol. 2005;53(1):1–37 (quiz 8–40).CrossRefPubMedGoogle Scholar
  20. 20.
    Sperling LC, Sinclair RD, Shabrawi-Caelen LE. Alopecias. In: Bolognia JL, Jorizzo JL, Schaffer A, editors. Dermatology. New York: Elsevier Saunders; 2012. p. 1093–112.Google Scholar
  21. 21.
    Costner MI, Sontheimer RD, Provost TT. Cutaneous manifestations of rheumatic diseases. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2004.Google Scholar
  22. 22.
    Callen JP. Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch Dermatol. 1982;118(6):412–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Millard LG, Rowell NR. Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients. Arch Dermatol. 1979;115(9):1055–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Gronhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011;164(6):1335–41.CrossRefPubMedGoogle Scholar
  25. 25.
    O’Brien JC, Chong BF. Not just skin deep: systemic disease involvement in patients with cutaneous lupus. J Investig Dermatol Symp Proc. 2017;18(2):S69–74.CrossRefPubMedGoogle Scholar
  26. 26.
    Merola JF, Prystowsky SD, Iversen C, Gomez-Puerta JA, Norton T, Tsao P, et al. Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. J Am Acad Dermatol. 2013;69(1):19–24.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Alarcon GS, McGwin G Jr, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP, et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus. 2002;11(2):95–101.CrossRefPubMedGoogle Scholar
  28. 28.
    Herzinger T, Plewig G, Rocken M. Use of sunscreens to protect against ultraviolet-induced lupus erythematosus. Arthritis Rheum. 2004;50(9):3045–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Bockle BC, Sepp NT. Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients. Lupus. 2015;24(7):669–74.CrossRefPubMedGoogle Scholar
  30. 30.
    Garza-Mayers AC, McClurkin M, Smith GP. Review of treatment for discoid lupus erythematosus. Dermatol Ther. 2016;29(4):274–83.CrossRefPubMedGoogle Scholar
  31. 31.
    Peters MS, Su WP. Lupus erythematosus panniculitis. Med Clin North Am. 1989;73(5):1113–26.CrossRefPubMedGoogle Scholar
  32. 32.
    Arai S, Katsuoka K. Clinical entity of Lupus erythematosus panniculitis/lupus erythematosus profundus. Autoimmun Rev. 2009;8(6):449–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Grossberg E, Scherschun L, Fivenson DP. Lupus profundus: not a benign disease. Lupus. 2001;10(7):514–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Marzano AV, Tanzi C, Caputo R, Alessi E. Sclerodermic linear lupus panniculitis: report of two cases. Dermatology. 2005;210(4):329–32.CrossRefPubMedGoogle Scholar
  35. 35.
    Sanchez NP, Peters MS, Winkelmann RK. The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol. 1981;5(6):673–80.CrossRefPubMedGoogle Scholar
  36. 36.
    Park HS, Choi JW, Kim BK, Cho KH. Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies. Am J Dermatopathol. 2010;32(1):24–30.CrossRefPubMedGoogle Scholar
  37. 37.
    LeBlanc RE, Tavallaee M, Kim YH, Kim J. Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis. Am J Surg Pathol. 2016;40(6):745–54.CrossRefPubMedGoogle Scholar
  38. 38.
    Martens PB, Moder KG, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J Rheumatol. 1999;26(1):68–72.PubMedGoogle Scholar
  39. 39.
    Ng PP, Tan SH, Tan T. Lupus erythematosus panniculitis: a clinicopathologic study. Int J Dermatol. 2002;41(8):488–90.CrossRefPubMedGoogle Scholar
  40. 40.
    Aronson IK, Fishman PM, Worobec SM. Disorders of subcutaneous tissue. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpattrick’s dermatology in general medicine. New York: McGraw Hill; 2012. p. 732–54.Google Scholar
  41. 41.
    Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Trueb RM. Involvement of scalp and nails in lupus erythematosus. Lupus. 2010;19(9):1078–86.CrossRefPubMedGoogle Scholar
  43. 43.
    Litt JZ. Litt’s drug eruptions and reactions manual. 22nd ed. Boca Raton: CRC Press, Taylor & Francis Group; 2016.Google Scholar
  44. 44.
    Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol. 2012;67(5):1040–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Patel M, Harrison S, Sinclair R. Drugs and hair loss. Dermatol Clin. 2013;31(1):67–73.CrossRefPubMedGoogle Scholar
  46. 46.
    Trueb RM. Chemotherapy-induced alopecia. Semin Cutan Med Surg. 2009;28(1):11–4.CrossRefPubMedGoogle Scholar
  47. 47.
    Sperling LC, Lupton GP. Histopathology of non-scarring alopecia. J Cutan Pathol. 1995;22(2):97–114.CrossRefPubMedGoogle Scholar
  48. 48.
    Ye Y, Zhao Y, Gong Y, Zhang X, Caulloo S, Zhang B, et al. Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata. Lupus. 2013;22(14):1439–45.CrossRefPubMedGoogle Scholar
  49. 49.
    Werth VP, White WL, Sanchez MR, Franks AG. Incidence of alopecia areata in lupus erythematosus. Arch Dermatol. 1992;128(3):368–71.CrossRefPubMedGoogle Scholar
  50. 50.
    Sontheimer RD, Provost TT. Lupus erythematosus. In: Sontheimer RD, Provost TT, editors. Cutaneous manifestations of rheumatic diseases. Baltimore: Williams and Wilkins; 1996.Google Scholar
  51. 51.
    Sperling LC, Cowper SE, Knopp EA. An atlas of hair pathology with clinical correlations. 2nd ed. London: Informa Healthcare; 2012.CrossRefGoogle Scholar
  52. 52.
    Piraccini BM, Broccoli A, Starace M, Gaspari V, D’Antuono A, Dika E, et al. Hair and scalp manifestations in secondary syphilis: epidemiology. Clinical features and trichoscopy. Dermatology. 2015;231(2):171–6.CrossRefPubMedGoogle Scholar
  53. 53.
    Ye Y, Zhang X, Zhao Y, Gong Y, Yang J, Li H, et al. The clinical and trichoscopic features of syphilitic alopecia. J Dermatol Case Rep. 2014;8(3):78–80.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Bernardez C, Molina-Ruiz AM, Requena L. Histologic features of alopecias-part I: nonscarring alopecias. Actas Dermosifiliogr. 2015;106(3):158–67.CrossRefPubMedGoogle Scholar
  55. 55.
    Armas-Cruz R, Harnecker J, Ducach G, Jalil J, Gonzalez F. Clinical diagnosis of systemic lupus erythematosus. Am J Med. 1958;25(3):409–19.CrossRefPubMedGoogle Scholar
  56. 56.
    Alarcon-Segovia D, Cetina JA. Lupus hair. Am J Med Sci. 1974;267(4):241–2.CrossRefPubMedGoogle Scholar
  57. 57.
    Trueb RM, El Shabrawi-Caelen L, Kempf W. Cutaneous lupus erythematosus presenting as frontal fibrosing alopecia: report of 2 patients. Skin Appendage Disord. 2017;3(4):205–10.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Nagai Y, Ishikawa O, Hattori T, Ogawa T. Linear lupus erythematosus profundus on the scalp following the lines of Blaschko. Eur J Dermatol. 2003;13(3):294–6.PubMedGoogle Scholar
  59. 59.
    Lueangarun S, Subpayasarn U, Chakavittumrong P, Tempark T, Suthiwartnarueput W. Lupus panniculitis of the scalp presenting with linear alopecia along the lines of Blaschko. Clin Exp Dermatol. 2017;42(6):705–7.CrossRefPubMedGoogle Scholar
  60. 60.
    Chen YA, Hsu CK, Lee JY, Yang CC. Linear lupus panniculitis of the scalp presenting as alopecia along Blaschko’s lines: a distinct variant of lupus panniculitis in East Asians? J Dermatol. 2012;39(4):385–8.CrossRefPubMedGoogle Scholar
  61. 61.
    Sonntag M, Lehmann P, Megahed M, Ruzicka T, Kuhn A. Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology. 2003;206(4):326–9.CrossRefPubMedGoogle Scholar
  62. 62.
    Lee WS, Chung J, Ahn SK. Mucinous lupus alopecia associated with papulonodular mucinosis as a new manifestation of lupus erythematosus. Int J Dermatol. 1996;35(1):72–3.CrossRefPubMedGoogle Scholar
  63. 63.
    Smith KJ, Skelton H. Basaloid follicular hamartomas associated with autoimmune disease: a possible role for retinoids in therapy. J Am Acad Dermatol. 2003;49(6):1067–70.CrossRefPubMedGoogle Scholar
  64. 64.
    Morton S, Stevens A, Powell RJ. Basaloid follicular hamartoma, total body hair loss and SLE. Lupus. 1998;7(3):207–9.CrossRefPubMedGoogle Scholar
  65. 65.
    Akasaka T, Kon S, Mihm MC Jr. Multiple basaloid cell hamartoma with alopecia and autoimmune disease (systemic lupus erythematosus). J Dermatol. 1996;23(11):821–4.CrossRefPubMedGoogle Scholar
  66. 66.
    Eastham AB, Velez NF, Chesebro AL, Townsend HB, Vleugels RA. Diffuse dystrophic calcinosis cutis of the scalp in a patient with scalp discoid lupus erythematosus and systemic lupus erythematosus. JAMA Dermatol. 2013;149(2):246–8.CrossRefPubMedGoogle Scholar
  67. 67.
    Chorzelski TP, Jablonska S, Blaszyczyk M, Fabjanska L. Annular atrophic plaques of the face. A variety of atrophic discoid lupus erythematosus? Arch Dermatol. 1976;112(8):1143–5.CrossRefPubMedGoogle Scholar
  68. 68.
    Umbert P, Winkelmann RK. Concurrent localized scleroderma and discoid lupus erythematosus. Cutaneous ‘mixed’ or ‘overlap’ syndrome. Arch Dermatol. 1978;114(10):1473–8.CrossRefPubMedGoogle Scholar
  69. 69.
    Rao BK, Coldiron B, Freeman RG, Sontheimer RD. Subacute cutaneous lupus erythematosus lesions progressing to morphea. J Am Acad Dermatol. 1990;23(5 Pt 2):1019–22.CrossRefPubMedGoogle Scholar
  70. 70.
    Stork J, Vosmik F. Lupus erythematosus panniculitis with morphea-like lesions. Clin Exp Dermatol. 1994;19(1):79–82.CrossRefPubMedGoogle Scholar
  71. 71.
    Julia M, Mascaro JM Jr, Guilabert A, Navarra E, Ferrando J, Herrero C. Sclerodermiform linear lupus erythematosus: a distinct entity or coexistence of two autoimmune diseases? J Am Acad Dermatol. 2008;58(4):665–7.CrossRefPubMedGoogle Scholar
  72. 72.
    Mir A, Tlougan B, O’Reilly K, Tzu J, Meehan S, Kamino H, et al. Morphea with discoid lupus erythematosus. Dermatol Online J. 2011;17(10):10.PubMedGoogle Scholar
  73. 73.
    Khelifa E, Masouye I, Pham HC, Parmentier L, Borradori L. Linear sclerodermic lupus erythematosus, a distinct variant of linear morphea and chronic cutaneous lupus erythematous. Int J Dermatol. 2011;50(12):1491–5.CrossRefPubMedGoogle Scholar
  74. 74.
    Pascucci A, Lynch PJ, Fazel N. Lupus erythematosus and localized scleroderma coexistent at the same sites: a rare presentation of overlap syndrome of connective-tissue diseases. Cutis. 2016;97(5):359–63.PubMedGoogle Scholar
  75. 75.
    Seyahi E, Seyahi N, Fresko I, Kuyumcu M, Yazici H. Hair diameter in systemic lupus erythematosus. Lupus. 2006;15(5):282–4.CrossRefPubMedGoogle Scholar
  76. 76.
    Ricci F, De Simone C, Del Regno L, Peris K. Drug-induced hair colour changes. Eur J Dermatol. 2016;26(6):531–6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Dermatology, Faculty of Medicine, Ramathibodi HospitalMahidol UniversityBangkokThailand

Personalised recommendations